Camelus dromedarius (Arabian camel): 105085024
Help
Entry
105085024 CDS
T04642
Symbol
PLCG1
Name
(RefSeq) 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 isoform X1
KO
K01116
phosphatidylinositol phospholipase C, gamma-1 [EC:
3.1.4.11
]
Organism
cdk
Camelus dromedarius (Arabian camel)
Pathway
cdk00562
Inositol phosphate metabolism
cdk01100
Metabolic pathways
cdk01521
EGFR tyrosine kinase inhibitor resistance
cdk04012
ErbB signaling pathway
cdk04014
Ras signaling pathway
cdk04015
Rap1 signaling pathway
cdk04020
Calcium signaling pathway
cdk04062
Chemokine signaling pathway
cdk04064
NF-kappa B signaling pathway
cdk04066
HIF-1 signaling pathway
cdk04070
Phosphatidylinositol signaling system
cdk04072
Phospholipase D signaling pathway
cdk04360
Axon guidance
cdk04370
VEGF signaling pathway
cdk04613
Neutrophil extracellular trap formation
cdk04650
Natural killer cell mediated cytotoxicity
cdk04658
Th1 and Th2 cell differentiation
cdk04659
Th17 cell differentiation
cdk04660
T cell receptor signaling pathway
cdk04664
Fc epsilon RI signaling pathway
cdk04666
Fc gamma R-mediated phagocytosis
cdk04670
Leukocyte transendothelial migration
cdk04722
Neurotrophin signaling pathway
cdk04750
Inflammatory mediator regulation of TRP channels
cdk04919
Thyroid hormone signaling pathway
cdk04933
AGE-RAGE signaling pathway in diabetic complications
cdk04935
Growth hormone synthesis, secretion and action
cdk05012
Parkinson disease
cdk05022
Pathways of neurodegeneration - multiple diseases
cdk05135
Yersinia infection
cdk05167
Kaposi sarcoma-associated herpesvirus infection
cdk05170
Human immunodeficiency virus 1 infection
cdk05171
Coronavirus disease - COVID-19
cdk05200
Pathways in cancer
cdk05205
Proteoglycans in cancer
cdk05206
MicroRNAs in cancer
cdk05214
Glioma
cdk05223
Non-small cell lung cancer
cdk05225
Hepatocellular carcinoma
cdk05231
Choline metabolism in cancer
cdk05235
PD-L1 expression and PD-1 checkpoint pathway in cancer
cdk05417
Lipid and atherosclerosis
Module
cdk_M00130
Inositol phosphate metabolism, PI=> PIP2 => Ins(1,4,5)P3 => Ins(1,3,4,5)P4
Brite
KEGG Orthology (KO) [BR:
cdk00001
]
09100 Metabolism
09101 Carbohydrate metabolism
00562 Inositol phosphate metabolism
105085024 (PLCG1)
09130 Environmental Information Processing
09132 Signal transduction
04012 ErbB signaling pathway
105085024 (PLCG1)
04014 Ras signaling pathway
105085024 (PLCG1)
04015 Rap1 signaling pathway
105085024 (PLCG1)
04370 VEGF signaling pathway
105085024 (PLCG1)
04064 NF-kappa B signaling pathway
105085024 (PLCG1)
04066 HIF-1 signaling pathway
105085024 (PLCG1)
04020 Calcium signaling pathway
105085024 (PLCG1)
04070 Phosphatidylinositol signaling system
105085024 (PLCG1)
04072 Phospholipase D signaling pathway
105085024 (PLCG1)
09150 Organismal Systems
09151 Immune system
04613 Neutrophil extracellular trap formation
105085024 (PLCG1)
04650 Natural killer cell mediated cytotoxicity
105085024 (PLCG1)
04660 T cell receptor signaling pathway
105085024 (PLCG1)
04658 Th1 and Th2 cell differentiation
105085024 (PLCG1)
04659 Th17 cell differentiation
105085024 (PLCG1)
04664 Fc epsilon RI signaling pathway
105085024 (PLCG1)
04666 Fc gamma R-mediated phagocytosis
105085024 (PLCG1)
04670 Leukocyte transendothelial migration
105085024 (PLCG1)
04062 Chemokine signaling pathway
105085024 (PLCG1)
09152 Endocrine system
04935 Growth hormone synthesis, secretion and action
105085024 (PLCG1)
04919 Thyroid hormone signaling pathway
105085024 (PLCG1)
09156 Nervous system
04722 Neurotrophin signaling pathway
105085024 (PLCG1)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
105085024 (PLCG1)
09158 Development and regeneration
04360 Axon guidance
105085024 (PLCG1)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
105085024 (PLCG1)
05206 MicroRNAs in cancer
105085024 (PLCG1)
05205 Proteoglycans in cancer
105085024 (PLCG1)
05231 Choline metabolism in cancer
105085024 (PLCG1)
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
105085024 (PLCG1)
09162 Cancer: specific types
05225 Hepatocellular carcinoma
105085024 (PLCG1)
05214 Glioma
105085024 (PLCG1)
05223 Non-small cell lung cancer
105085024 (PLCG1)
09172 Infectious disease: viral
05170 Human immunodeficiency virus 1 infection
105085024 (PLCG1)
05171 Coronavirus disease - COVID-19
105085024 (PLCG1)
05167 Kaposi sarcoma-associated herpesvirus infection
105085024 (PLCG1)
09171 Infectious disease: bacterial
05135 Yersinia infection
105085024 (PLCG1)
09164 Neurodegenerative disease
05012 Parkinson disease
105085024 (PLCG1)
05022 Pathways of neurodegeneration - multiple diseases
105085024 (PLCG1)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
105085024 (PLCG1)
09167 Endocrine and metabolic disease
04933 AGE-RAGE signaling pathway in diabetic complications
105085024 (PLCG1)
09176 Drug resistance: antineoplastic
01521 EGFR tyrosine kinase inhibitor resistance
105085024 (PLCG1)
09180 Brite Hierarchies
09182 Protein families: genetic information processing
04131 Membrane trafficking [BR:
cdk04131
]
105085024 (PLCG1)
Enzymes [BR:
cdk01000
]
3. Hydrolases
3.1 Acting on ester bonds
3.1.4 Phosphoric-diester hydrolases
3.1.4.11 phosphoinositide phospholipase C
105085024 (PLCG1)
Membrane trafficking [BR:
cdk04131
]
Exocytosis
Calcium ion-dependent exocytosis
Phospholipases
105085024 (PLCG1)
Endocytosis
Macropinocytosis
Phospholipase C
105085024 (PLCG1)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
PI-PLC-X
SH2
PI-PLC-Y
SH3_1
PH
C2
SH3_9
SH3_2
PH_12
GDPD
EF-hand_6
EF-hand_7
PH_9
Motif
Other DBs
NCBI-GeneID:
105085024
NCBI-ProteinID:
XP_031289659
LinkDB
All DBs
Position
19:complement(16433924..16473622)
Genome browser
AA seq
1383 aa
AA seq
DB search
MAGAASPCANGCGPGAPSDAEVLNLCRNLEVGTVMTLFYSKKSQRPERKTFQVKLETRQI
IWSRGADKFEGAIDIREIKEIRPGKTSRDFDRYQEDPAFRPDQSHCFVILYGMEFRLKTL
SLQATSEDEVNMWIKGLTWLMEDTLQAATPLQIERWLRKQFYSVDRNHEDRISAKDLKNM
LSQVNYRVPNMRFLRERLTDLEQRTSDITYGQFAQLYRSLMYSAQKTMDLPFLEASALRA
GERPELCRVSLPEFQQFLLEYQGELWAVDRLQVQEFMLSFLRDPLREIEEPYFFLEEFVT
FLFSKENSVWNSQLDAVCPDTMNNPLSHYWISSSHNTYLTGDQFSSESSLEAYARCLRMG
CRCIELDCWDGPDGMPVIYHGHTLTTKIKFSDVLHTIKEHAFVASEYPVILSIEDHCSIA
QQRNMAQHFRKVLGDTLLTKPVDIAADGLPSPNQLKRKILIKHKKLAEGSAYEEVPTSVM
YSENDISNSIKNGILYLEDPVNHEWYPHYFVLTSSKIYYSEETSSDQGNEDEEEPKEASG
GTELHSNEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFW
RNGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQT
NAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQE
GQTVMLGNSEFDSLVDLVSYYERHPLYRKMKLRYPINEEALEKIGTAEPDYGALYEGRNP
GFYVEANPMPTFKCAVKALFDYKAQREDELTFTKSAIIQNVEKQEGGWWRGDYGGKKQLW
FPSNYVEEMVSPAALEPEREHLDENSPLGDLLRGVLDVPACQIGTVDAAAGQLTSTVLMG
WSLRVTATWRQEGRGTWPQVAVTCHWAAASSAVKQAWQSSGTSSRGTGWGDGDTFVPQLC
SPLPLAIRPEGKNNRLFVFSISMASVAHWSLDVAADSQEELQDWVKKIREVAQTADARLT
EGKMMERRKKIALELSELVVYCRPVPFDEDKIGTERACYRDMSSFPETKAEKYVNKAKGK
KFLQYNRLQLSRIYPKGQRLDSSNYDPLPMWICGSQLVALNFQTPDKPMQMNQALFMAGG
HCGYVLQPSTMRDEAFDPFDKSSLRGLEPCAISIEVLGARHLPKNGRGIVCPFVEIEVAG
AEYDSTKQKTEFVVDNGLNPVWPAKPFHFQISNPEFAFLRFVVYEEDMFSDQNFLAQATF
LVKGLKTGYRAVPLKNNYSEDLELASLLVKIDVFPAKQENGDLSPFGGASLRERGCDASG
QLFHGRAREGSFEARYQQPFEDFRISQEHLSDHFDSRERSIILATPLFFPEEAPEWTEPC
GRQ
NT seq
4152 nt
NT seq
+upstream
nt +downstream
nt
atggcgggcgccgcgtccccctgcgccaatggctgcgggcccggcgcgccctcggacgct
gaggtgctgaacctctgccgcaacctcgaggtgggcaccgtcatgactttgttctactcc
aagaagtcgcagcggcccgagcggaagaccttccaggtcaagctggagacgcggcagatc
atatggagccgtggcgccgacaagttcgagggggccatcgatattcgtgaaatcaaggag
atccgcccagggaagacctcacgggactttgaccgctaccaagaggatcctgcttttcga
ccagaccagtcacactgctttgtcatcctgtatggaatggaattccgcctgaagactttg
agcttgcaagccacgtctgaggacgaagtgaacatgtggatcaagggcttgacttggctg
atggaggatacattgcaggcggccacacccctgcagattgagaggtggctgcggaagcag
ttctactcagtggaccggaatcatgaggatcgtatatcagccaaggacctgaagaacatg
ctgtcccaggtcaactaccgggtccccaacatgcgcttcctccgagagcgactgacggac
ctggagcagcgcaccagcgacatcacctatgggcagtttgctcagctgtaccgcagcctc
atgtacagcgcccagaagacgatggacctccccttcctggaagccagtgccctgagggcg
ggggagcggccggagctctgccgggtgtcccttcctgagttccagcaattcctcctcgag
taccagggggagctgtgggctgttgaccggctccaagtgcaggagttcatgctcagcttc
ctccgagaccccttgcgagagatcgaggagccttacttcttcctggaagagtttgtcacc
ttcctgttctccaaggagaacagtgtgtggaactcgcagctggacgccgtgtgcccagac
accatgaacaatcctctctcccactactggatctcctcctcacacaacacgtacctgact
ggtgaccagttctccagcgagtcctccctggaagcctacgctcgctgcctgcggatgggc
tgtcgctgcattgagttggactgctgggatggcccagacgggatgccagtcatttaccat
ggacacaccttgaccaccaagatcaagttctcagacgtcctgcacaccatcaaggagcac
gcctttgtggcctcagagtacccagtcatcctgtccatcgaggaccactgcagcatcgcc
cagcagaggaacatggcccagcacttcaggaaggtgctcggggacacactcctcaccaag
cccgtggacatcgccgccgacgggctcccctcacccaaccagctcaagaggaagatcctc
atcaagcacaagaagctggctgagggcagtgcctatgaggaggtgcctacgtccgtgatg
tactctgagaacgacatcagcaactccatcaagaacggcattctctacctggaggacccc
gtgaaccacgagtggtatccccactactttgttctgaccagcagcaaaatctactactct
gaggagaccagcagtgaccagggcaatgaggacgaagaggagcccaaggaggccagcggc
ggcacagagctgcactccaacgagaagtggttccatgggaagctcggggcggggcgggac
gggcgacacatcgccgagcgcctgcttacagagtactgcatcgagaccggggcacccgac
ggctccttcctcgtgcgcgagagcgagaccttcgtgggtgactacaccctctccttctgg
cggaacgggaaagtccagcactgccggatccactctcggcaggacgctgggacccccaag
ttcttcctgacagacaacctcgtcttcgactcactctatgacctcatcacgcactaccag
caggttcccctgcgctgcaacgaatttgagatgcgcctctcagagcccgtcccacagacc
aacgcccacgagagcaaagagtggtaccacgccagcctgaccagagcacaggccgagcac
atgctgatgcgcgtaccccgggatggggccttcctggtgcggaaacggaatgagcccaac
tcctacgccatctccttccgggctgaggggaagatcaagcactgccgagtccagcaggag
ggccagactgtgatgctgggcaactcagagtttgacagcctcgttgacctcgtcagctac
tatgagaggcaccccctgtaccgcaagatgaagctgcgctatcccatcaatgaggaggcg
ctggagaagatcggcacggctgagcctgactatggagcgctgtacgaggggcgcaaccct
ggcttctacgtggaggcaaaccccatgccaactttcaagtgtgccgtcaaagctctcttt
gactataaggcccagagagaagatgagctgacttttaccaagagtgccatcatccagaac
gtggagaagcaagagggaggctggtggcggggggactatggtgggaagaagcagctgtgg
ttcccttcaaactacgtggaagagatggtcagcccagcagccctggagcctgagagggag
cacttggatgagaacagccccctgggggacttgctgcggggggtcttggatgtgccagct
tgtcagataggcaccgtggatgctgctgctggccagctgacatccacagtcctgatgggt
tggtccctgcgtgtgacagcgacgtggagacaggaggggaggggcacatggccccaagta
gcagtgacttgtcactgggctgcagcatcctcagctgtaaaacaggcctggcagagcagt
ggcacctcatctcggggcacggggtggggggacggggacacatttgtcccccagctctgc
tctcctctccctctagccatccgtcccgagggcaagaacaaccggctgttcgtcttctcc
atcagtatggcatcagtggcacactggtccctggatgtggctgctgactcacaggaggag
ctgcaggactgggtgaaaaagatccgagaagtagcccagactgcggatgccaggctcaca
gaggggaagatgatggagcggaggaagaagatcgccctggagctctcggagcttgttgtc
tactgccggcctgttcccttcgacgaagacaagatcggcacagaacgcgcttgctaccgg
gacatgtcatccttcccggaaaccaaggctgagaaatacgtgaacaaggccaaaggcaag
aagttcctccagtacaaccggctgcagctgtcccgcatctaccccaagggccagcggctg
gactcctccaactatgaccctttgcccatgtggatctgtggcagtcagctggtggccctc
aacttccagaccccagacaagcccatgcagatgaaccaggccctcttcatggccggcggg
cactgtggctacgtgctgcagcccagcaccatgcgggacgaggccttcgaccccttcgac
aagagcagcctccgggggctggagccgtgtgctatctccatcgaggtgctgggggcccga
catctgccgaagaacggccggggcatcgtgtgtccttttgtggagattgaggtggctgga
gcagaatatgacagcaccaagcagaagacagagtttgtggtggacaacggactgaaccct
gtgtggccagccaagcccttccacttccagatcagtaaccccgaattcgccttcctgcgt
ttcgtggtgtatgaggaagacatgtttagtgaccagaacttcctggctcaggccaccttc
ttggtgaagggcctgaagacgggatacagagcggtgcctttgaagaacaactacagtgag
gacctggagctggcctccctgctcgtcaagatagatgttttccctgccaagcaggagaac
ggcgacctgagtccattcggcggggcatccctgcgggagcgaggctgcgacgcctcgggc
cagctatttcatgggcgggcccgggaaggctcctttgaagcccgctaccagcagccattt
gaggacttccgcatctcccaggagcatctctcggaccattttgacagtcgggaacgaagc
ataattttggcaacaccgctgttctttccagaggaggcaccagagtggaccgagccgtgt
gggagacagtga
DBGET
integrated database retrieval system